SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LEGN

Legend Biotech Corp (NASDAQ:LEGN)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
20.41+1.14 (+5.89%)
 
Market cap
$3.77B
Analyst consensus
Listed since
Jun 5, 2020
Insider Score
––Not scored
LEGN Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

LEGN analyst forecast

LEGN analyst consensus

No analyst ratings in the last 3 months.

LEGN 12-month price target

$56.00+172.3% upsideaverage of 1 firm
$56.00High
$56.00Low

Best analysts covering LEGN

No firm covering LEGN has enough calls with a finished 1Y holding period to rank yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

LEGN analyst ratings

FirmPrice targetAction
RBC Capital—$56.00+207.9%—2026-10-08
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.